At the same time, MAP4K1, G6PD, CDK18, SOCS1, ETS2, and AKR1B1 showed opposite trends (Supplementary Figures S2C,S2F), suggesting that KDM5B and SMURF2 might be protective factors for AML patients. The gene discussed is KDM5B; the disease is acute myeloid leukemia.